Fields »
ABOUT
HELP
BLOG

551 GENES FOUND

Show / hide columns

XML | RDF | TSV | « prev | Page of 12 | next »

Gene

 

 

Gene description

x

 

 

Protein class

x

 

 

 

 

Tissue

Cell

Pathology

 

 

 

 

 

 

Subcellular location

x

 

 

RNA tissue category

x

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 
KCNQ2Potassium channel, voltage gated KQT-like subfamily Q, member 2Disease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Endoplasmic reticulumTissue enriched
KDRKinase insert domain receptorCancer-related genes
CD markers
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
RAS pathway related proteins
Plasma membraneTissue enhanced
KEAP1Kelch-like ECH-associated protein 1Cancer-related genes
FDA approved drug targets
Predicted intracellular proteins
Nucleoplasm
Microtubule organizing center
Cytosol		Expressed in all
KITV-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homologCancer-related genes
CD markers
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
RAS pathway related proteins
Plasma membraneTissue enhanced
LCKLCK proto-oncogene, Src family tyrosine kinaseCancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
Golgi apparatusTissue enhanced
LEPRLeptin receptorCancer-related genes
Candidate cardiovascular disease genes
CD markers
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
VesiclesMixed
LHCGRLuteinizing hormone/choriogonadotropin receptorDisease related genes
FDA approved drug targets
G-protein coupled receptors
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Group enriched
LIPFLipase, gastricEnzymes
FDA approved drug targets
Predicted secreted proteins
Tissue enriched
LPLLipoprotein lipaseCandidate cardiovascular disease genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
VesiclesTissue enhanced
M6PRMannose-6-phosphate receptor (cation dependent)FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Expressed in all
MAOAMonoamine oxidase ADisease related genes
Enzymes
FDA approved drug targets
Predicted membrane proteins
MitochondriaMixed
MAOBMonoamine oxidase BEnzymes
FDA approved drug targets
Predicted membrane proteins
Nucleoli
Mitochondria		Mixed
MAP1AMicrotubule-associated protein 1AFDA approved drug targets
Plasma proteins
Predicted intracellular proteins
CytosolTissue enriched
MAP2Microtubule-associated protein 2FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Nucleoli
Cytosol		Tissue enriched
MAP2K1Mitogen-activated protein kinase kinase 1Cancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
RAS pathway related proteins
Plasma membrane
Cytosol		Expressed in all
MAP2K2Mitogen-activated protein kinase kinase 2Cancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
RAS pathway related proteins
CytosolExpressed in all
MAP4Microtubule-associated protein 4FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Plasma membrane
Microtubules
Cytosol		Expressed in all
MAPK1Mitogen-activated protein kinase 1Cancer-related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
RAS pathway related proteins
Expressed in all
MAPK11Mitogen-activated protein kinase 11Enzymes
FDA approved drug targets
Predicted intracellular proteins
MitochondriaMixed
MAPK3Mitogen-activated protein kinase 3Cancer-related genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
RAS pathway related proteins
NucleoplasmExpressed in all
MAPTMicrotubule-associated protein tauCandidate cardiovascular disease genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Nuclear speckles
Plasma membrane		Tissue enriched
METMET proto-oncogene, receptor tyrosine kinaseCancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
RAS pathway related proteins
Plasma membrane
Cytosol		Mixed
METAP2Methionyl aminopeptidase 2Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Plasma membrane
Cytosol		Expressed in all
MGAMMaltase-glucoamylaseEnzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Tissue enhanced
MMEMembrane metallo-endopeptidaseCancer-related genes
Candidate cardiovascular disease genes
CD markers
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Tissue enhanced
MMP1Matrix metallopeptidase 1Cancer-related genes
Candidate cardiovascular disease genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
VesiclesTissue enhanced
MMP10Matrix metallopeptidase 10Cancer-related genes
Enzymes
FDA approved drug targets
Predicted secreted proteins
Plasma membrane
Cytosol		Tissue enriched
MMP11Matrix metallopeptidase 11Cancer-related genes
Enzymes
FDA approved drug targets
Predicted secreted proteins
Group enriched
MMP14Matrix metallopeptidase 14 (membrane-inserted)Cancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Intermediate filaments
Cytosol		Mixed
MMP15Matrix metallopeptidase 15 (membrane-inserted)Cancer-related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Nucleoplasm
Plasma membrane
Cytosol		Tissue enhanced
MMP16Matrix metallopeptidase 16 (membrane-inserted)Cancer-related genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Vesicles
Cytosol		Tissue enhanced
MMP19Matrix metallopeptidase 19Enzymes
FDA approved drug targets
Predicted secreted proteins
Endoplasmic reticulum
Vesicles		Tissue enhanced
MMP2Matrix metallopeptidase 2Cancer-related genes
Candidate cardiovascular disease genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Vesicles
Cytosol		Tissue enhanced
MMP24Matrix metallopeptidase 24 (membrane-inserted)Enzymes
FDA approved drug targets
Predicted membrane proteins
Nucleoli
Plasma membrane		Tissue enhanced
MMP25Matrix metallopeptidase 25Enzymes
FDA approved drug targets
Predicted intracellular proteins
Predicted secreted proteins
Tissue enhanced
MMP27Matrix metallopeptidase 27Enzymes
FDA approved drug targets
Predicted secreted proteins
Group enriched
MMP3Matrix metallopeptidase 3Cancer-related genes
Candidate cardiovascular disease genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
VesiclesTissue enhanced
MMP7Matrix metallopeptidase 7Cancer-related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Nucleoplasm
Vesicles		Tissue enhanced
MMP8Matrix metallopeptidase 8Cancer-related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Tissue enriched
MMP9Matrix metallopeptidase 9Cancer-related genes
Candidate cardiovascular disease genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
CytosolTissue enhanced
MPLMPL proto-oncogene, thrombopoietin receptorCancer-related genes
CD markers
Disease related genes
FDA approved drug targets
Predicted membrane proteins
Plasma membraneTissue enhanced
MR1Major histocompatibility complex, class I-relatedFDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Plasma membraneMixed
MS4A1Membrane-spanning 4-domains, subfamily A, member 1CD markers
Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Group enriched
MS4A2Membrane-spanning 4-domains, subfamily A, member 2FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Tissue enhanced
MTORMechanistic target of rapamycin (serine/threonine kinase)Cancer-related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Vesicles
Cytosol		Expressed in all
MTR5-methyltetrahydrofolate-homocysteine methyltransferaseDisease related genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
CytosolExpressed in all
MTTPMicrosomal triglyceride transfer proteinDisease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted secreted proteins
CytosolGroup enriched
MUTMethylmalonyl CoA mutaseDisease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Mitochondria
Cytosol		Expressed in all
NFKB1Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1Cancer-related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
RAS pathway related proteins
Transcription factors
Nucleoplasm
Cytosol		Expressed in all
NISCHNischarinFDA approved drug targets
Predicted intracellular proteins
Expressed in all

« prev | Page of 12 | next »

Contact

The Project

The Human Protein Atlas

The Human Protein Atlas project is funded
by the Knut & Alice Wallenberg foundation.